BillionToOne, Inc. (BLLN) stock analysis

In our weekly check, BillionToOne, Inc. is graded B (A to F). Of 19 checks on debt, profit, cash flow and trend: 14 pass, warnings: 2, red flags: 3.

About BillionToOne, Inc.

BillionToOne, Inc. is a Healthcare company (Medical - Diagnostics & Research) based in the United States, listed on NASDAQ as BLLN.

What our checks show for BLLN

Red flags

Warning signs

Strengths

Similar companies

GRAL · SHC · RDNT · CDNA · QGEN · NEO

Questions

What grade does BillionToOne, Inc. (BLLN) have?

In our weekly check, BillionToOne, Inc. is graded B (A to F). Of 19 checks on debt, profit, cash flow and trend: 14 pass, warnings: 2, red flags: 3. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of BLLN stock?

This week's biggest flags for BillionToOne, Inc.: Margins expected to shrink, Very volatile, Heavy stock pay. In total 5 of 19 checks show a warning or a red flag.

What does BillionToOne, Inc. do?

BillionToOne, Inc. is a Healthcare company (Medical - Diagnostics & Research) based in the United States, listed on NASDAQ as BLLN.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis